Abstract
Background and aims: We analyzed the efficacy of retreatment after protease inhibitors (PI) plus pegylated-interferon (pegIFN) and ribavirin (RBV)-failure with various IFN-free regimens, and the role of genotypic-resistance-testing (GRT) in real-life settings.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.